Entry Detail



General Information

Database ID:exR0369339
RNA Name:SCD
RNA Type:mRNA
Chromosome:chr10
Starnd:+
Coordinate:
Start Site(bp):100347233End Site(bp):100364826
External Links:ENSG00000099194



Disease Information

Disease Name:Amyotrophic Lateral Sclerosis
Disease Category:Nervous System Diseases
MeSH ID:D000690
Type:Diseases Category/Nervous System Diseases
Alias:Sclerosis, Amyotrophic Lateral//Gehrig's Disease//Gehrig Disease//Gehrigs Disease//Charcot Disease//Motor Neuron Disease, Amyotrophic Lateral Sclerosis//Lou Gehrig's Disease//Lou-Gehrigs Disease//Disease, Lou-Gehrigs//ALS - Amyotrophic Lateral Sclerosis//ALS Amyotrophic Lateral Sclerosis//Lou Gehrig Disease//Amyotrophic Lateral Sclerosis, Guam Form//Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1//Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1//Guam Form of Amyotrophic Lateral Sclerosis//Guam Disease//Disease, Guam//Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam//Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam//Amyotrophic Lateral Sclerosis With Dementia//Dementia With Amyotrophic Lateral Sclerosis



Expression Detail

GEO ID:GSE121519
Description:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid.
Experimental Design:Disease vs Control
Case Disease Type:Amyotrophic Lateral Sclerosis
Case Disease SubType:NA
Case Sample:Amyotrophic Lateral Sclerosis
Control Sample:Healthy
Number of Case:4
Number of Control:4
Number of Samples:8





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC010132.3
chr7
42909273
42932174
-
AC018523.2
chr11
14493783
14520344
-
AC048338.1
chr12
122207779
122266423
-
AC092143.1
chr16
89919165
89936092
+
AC120057.2
chr17
7240427
7244635
-
AC138811.2
chr16
18788063
18801519
-
ACP1
chr2
264140
278283
+
ACP6
chr1
147629652
147670524
-
ACTB
chr7
5527148
5563784
-
ACTG1
chr17
81509971
81523847
-
ACTR2
chr2
65227753
65271253
+
ADAR
chr1
154582057
154628013
-
ADSL
chr22
40346500
40390463
+
AEBP2
chr12
19404045
19720801
+
AGBL5
chr2
27042364
27070622
+
AGPS
chr2
177392757
177559299
+
AIG1
chr6
143060496
143341058
+
AKIRIN2
chr6
87674860
87702233
-
AL022238.4
chr22
40346529
40410054
+
ALDH7A1
chr5
126531200
126595362
-
ALDH9A1
chr1
165662216
165698863
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-7-5p
chr19
4770700
4770723
+
hsa-miR-185-5p
chr22
20033153
20033174
+
hsa-miR-1321
chrX
85835832
85835849
+
hsa-miR-1197
chr14
101025620
101025640
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC004816.1
chr14
70809841
70815994
+
AC005618.1
chr5
141326210
141329357
+
AC009446.1
chr8
71675300
71702786
+
AC010719.1
chr7
25948657
25949403
-
AC106795.2
chr5
177950335
177963960
+
AC106864.1
chr4
112693047
112706810
-
AC124068.2
chr15
89335053
89336161
+
AC124283.3
chr17
82578023
82578616
+
AC126365.1
chr17
20788071
20789584
+
AL132780.1
chr14
22929607
22956374
+
Display:



Experiment Detail

GEO ID:GSE121519
Sample Source:Cerebrospinal Fluid
Source Fraction:Exosome
Platform:GPL18573
Method:NGS
Num of detected RNA Type:2
Num of detected RNAs of this Type:17787
Sample treatment protocol:Up to 1 mL of human CSF was centrifuged at 2,000×g for 5 min and 10, 000×g for 20 min for supernatant.
RNA Extract protocol:Supernatant from final centrifugation was applied to exoRNeasy spin column and RNA was extracted.
RNA library preparation protocol:Whole cDNA amplification was performed with SMART-seq v4 Ultra Low Input RNA Kit. Illumina library was constructed with Nextera XT DNA Library Prep Kit.



Reference

PMID:30630471
Title:Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid
Author:Otake K, Kamiguchi H, Hirozane Y
Journal:BMC Med Genomics. 2019 Jan 10;12(1):7.
Description:The main purpose of this study is to established the methodology of comprehensive analysis of exosomal mRNAs in CSF by a highly sensitive next-generation sequencing.